Stryker Global Medical Device Registrations Dossier

A global registry dossier for Stryker Corporation, analyzing medical device registrations across 23 non-US markets and the integration of major acquisitions like Howmedica and Wright Medical.

Global Regulatory Dossier: Stryker

For regulatory affairs teams, market-access managers, and competitive intelligence analysts, understanding the global regulatory footprint of Stryker Corporation is essential. Stryker is a global powerhouse in medical technology, offering products in orthopaedics, medical and surgical equipment (MedSurg), and neurotechnology and spine.

This global data dossier analyzes the distribution of Stryker's product registrations across major international medical device databases. By compiling data from 34 national and regional registries across six continents, we examine where Stryker holds active registrations, how its extensive list of acquisitions—specifically Howmedica and Wright Medical (including Tornier)—are integrated into global databases, and the differences between its product approvals and local channel configurations.

Scenario Question & Direct Answer

How is Stryker's global medical device footprint distributed across major world markets, and how do its legacy acquisitions (Howmedica, Wright Medical) affect international registrations?

Stryker Corporation's global device registrations span 23 positive non-US markets, including 5,952 active licenses in Canada MDALL, 1,964 in Australia ARTG, 998 in Brazil ANVISA, 519 in India CDSCO, and 2,815 in Saudi Arabia SFDA. This sits alongside 2,056 US FDA 510(k) filings, 279 PMAs, and 79,352 UDI records. The data reflects Stryker's aggressive M&A history, with legacy acquisitions like Howmedica and Wright Medical (including Tornier) representing large shares of active registrations. Channel data indicates Stryker operates through direct subsidiaries in Singapore, Mexico, Korea, Brazil, Malaysia, and the UK.

The Global Evidence Map: Positive Registry Matches

To construct a reliable map of Stryker's global footprint, we inspected the official device registers of major markets. The table below represents positive matches where Stryker or its verified subsidiaries (Howmedica, Wright Medical, K2M, Leibinger, etc.) are listed as the manufacturer, sponsor, or license holder.

Jurisdiction / Market	Database Source	Active Records (Combined)	Manufacturer Entity Values Identified	Classification
United States	FDA CDRH (510k, PMA, Reg/Listing, UDI)	2,056 (510k) / 279 (PMA) / 5,675 (Reg) / 79,352 (UDI)	Stryker Corp; Howmedica Osteonics; Wright Medical Technology; Stryker Leibinger	POSITIVE
European Union	EUDAMED Public Devices & Actors	102 (Devices) / 41 (Actors) / 8 (Certs)	Stryker Corporation; Howmedica Osteonics Corp; Wright Medical; K2M	POSITIVE
Canada	Health Canada MDALL Active Licenses	5,952	Howmedica Osteonics; Stryker Corp; Wright Medical; Tornier; Novadaq	POSITIVE
Australia	TGA Australian Register of Therapeutic Goods (ARTG)	1,964	Stryker Australia Pty Ltd (Sponsor); Howmedica; Wright Medical; Tornier; Davol	POSITIVE
Brazil	ANVISA Medical Devices Database	998	Stryker do Brasil Ltda; Howmedica Osteonics; Wright Medical; Tornier	POSITIVE
India	CDSCO Approved Devices Register	519	Stryker India Pvt Ltd; Howmedica Osteonics; Wright Medical Technology	POSITIVE
Saudi Arabia	SFDA Medical Equipment List	2,815	Stryker Corp; Howmedica; Wright Medical; Tornier; Leibinger	POSITIVE
South Korea	MFDS Device Registrations	3,728	Stryker Korea Co Ltd; Howmedica; Wright Medical; K2M; Leibinger	POSITIVE
Taiwan	TFDA Registered Medical Devices	962	Stryker Corporation; Howmedica Osteonics; Wright Medical; Tornier	POSITIVE
Vietnam	MOH Approved Devices List	4	Stryker Sales Corporation (Representative Office)	POSITIVE
Indonesia	Kemkes Registered Medical Devices	58	Stryker Corporation; Rita Leibinger (brand-level matches)	POSITIVE
Singapore	HSA Registered Medical Devices	361	Stryker Singapore Pte Ltd (Registrant); Howmedica; Wright Medical	POSITIVE
Malaysia	MDA Registered Devices	204	Stryker Corporation (M) Sdn Bhd (Registrant)	POSITIVE
Mexico	COFEPRIS Health Registrations	71	Stryker México, S.A. de C.V.	POSITIVE
United Kingdom	MHRA Active Manufacturers	27	Stryker UK Ltd; Howmedica Osteonics; Wright Medical Technology	POSITIVE
Argentina	ANMAT Registered Medical Devices	111	Stryker Corporation; Howmedica Osteonics (held via local reps)	POSITIVE
Hong Kong	MDD Listed Medical Devices	295	Stryker Asia Pacific (LRP); Howmedica; Wright Medical; Tornier	POSITIVE
Israel	MOH Medical Device Register	296	Stryker Corporation; Howmedica; Wright Medical; Tornier; K2M	POSITIVE
Kazakhstan	NDDA Registered Medical Devices	16	Stryker brand listings in product names (local distributor registrations)	POSITIVE
Thailand	FDA Search Center (Terms)	160	Stryker Corporation; Howmedica; Wright Medical (term-sample)	POSITIVE
Jordan	JFDA Medical Devices List	3	Scraped HTML pages containing "Stryker Trauma Plating"	POSITIVE
Colombia	INVIMA Medical Devices Database	1,724	Stryker Colombia S.A.S.; Howmedica Osteonics; Wright Medical	POSITIVE

Registry Limitations & No-Hit Analysis

When conducting global intelligence sweeps, identifying where a company is not present or where data is constrained is just as important as mapping positive hits. The table below outlines the databases inspected where no active product registrations were found, or where the dataset imposes significant limitations.

Jurisdiction	Database Inspected	Finding / Negative Status	Technical Caveat / Database Limitation
Switzerland	swissdamed (UDI Details)	NO-HIT (Limitation)	27 matches found but all represent third-party compatible accessories ("battery suitable for Stryker"). Owner name matches are zero.
Ecuador	ARCSA Medical Devices	NO-HIT (Limitation)	108 matches found but all are product-name mentions of compatibility ("compatible with Stryker"). No Stryker-owned registrations.
Albania	AKBPM Medical Devices	NO-HIT (Limitation)	71 matches found but all are in the device-name field. 0 records list Stryker in the manufacturer (Prodhuesi) field.
Pakistan	DRAP Registered Devices	NO-HIT	Scoped strictly to local manufacturing establishments (cotton bandages, etc.), not imports. 0 Stryker matches across 12,666 records.
Qatar	MoPH Implantables	NO-HIT	0 Stryker records across 2,623 implantable-only records. Represents a coverage gap.
Bahrain	NHRA Registered Devices	NO-HIT	0 Stryker records across 1,491 registered products.
UAE	EDE Registered Devices	NO-HIT	0 Stryker records across 4,793 records (database skews heavily pharmaceutical).
Oman	MOH Medical Devices	NO-HIT	Single HTML landing page containing no device rows; no database search capability.
Ghana	FDA Product Registry	NO-HIT	Scoped mainly to food/drugs; 0 Stryker matches across all raw page files.
Nigeria	NAFDAC Greenbook	NO-HIT (Limitation)	Scoped to page 0 only (1,119 records); no Stryker records found.
Moldova	AMDM Medical Devices	NO-HIT (Limitation)	Status log and bootstrap pages only; no consolidations of device records.

Understanding Registry Data Limits: A Commercial Warning

A key mistake made by market analysts is treating medical device registration records as equivalent to market share, product sales, or clinical usage. It is critical to recognize the inherent limits of registry datasets:

Registrations are Not Sales: An active registration simply indicates that a device is legally cleared for commercial sale in that country. It does not mean the device is actively marketed, stocked, or utilized in local hospitals. Large manufacturers like Stryker frequently maintain hundreds of legacy registrations for products that are commercially inactive or have been replaced by newer generations.
Record Counts do Not Equal Unique SKUs: The unit of measurement in registries is the "record" or "line count". A single registration record can cover hundreds of individual catalog numbers (SKUs), packaging sizes, or product configurations. Conversely, a single product line might be split across multiple registration records due to manufacturing site variations or component classifications.
Vigilance and Recalls reflect Report Counts, not Safety Incidence: In public safety databases (such as the US FDA Recall and Enforcement databases, which list 2,839 and 1,573 Stryker-related entries respectively), counts reflect administrative actions and reporting volume. Because Stryker holds a vast market share in high-volume surgical instruments, orthopedic implants, and patient handling equipment, the sheer volume of products in circulation naturally correlates to a higher absolute number of reports, which does not represent a higher defect rate.
Distributor Lists are Channel Evidence, Not Approvals: In databases listing authorized importers or distributors, the presence of a Stryker entity indicates a commercial channel setup rather than a technical product approval. A local distributor must be licensed to import, but they can only import products that have separately secured technical registration certificates.

Detailed Market Profiles & Registry Insights

To understand Stryker's global footprint, we must look beyond numbers and inspect how Stryker is represented in specific key databases. Below is a detailed breakdown of the registries where Stryker has its most significant presence.

1. United States: FDA CDRH Database

The United States represents Stryker's home market and holds the largest concentration of records. By querying the FDA CDRH databases, we can see the full historical scale of Stryker's filings:

FDA 510(k): Out of 175,149 active and historical 510(k) records, the combined query returns 2,056 matches. The vast majority of these are held by Howmedica Osteonics Corp (1,282), with 902 under Stryker Corp itself. A sample record includes K233456 for Stryker's Mako Robotic-Arm Assisted System, representing its dominance in robotic orthopaedic surgery.
FDA PMA: For high-risk Class III devices, the PMA database (56,508 records) contains 279 matches. Legacy acquisitions represent large shares of active PMAs, reflecting Stryker's focus on neurovascular implants and specialized surgical sealants.
FDA Registration & Listing: Out of 417,036 registered establishments and listing records, there are 5,675 combined matches, highlighting the extensive manufacturing footprint of the group.
FDA Unique Device Identification (UDI): The Global UDI Database (GUDID), which tracks individual device models, contains 79,352 listings associated with the company, representing the vast catalog of orthopedic implants, screws, plates, and surgical instruments.

2. Canada: Health Canada MDALL

Health Canada's Medical Devices Active License Listing (MDALL) represents one of the cleanest product-level registries in the world. It tracks active licenses for Class II, III, and IV medical devices:

Denominator: 152,560 active license records.
Combined Stryker Matches: 5,952 active licenses.
Analysis: This register shows that Howmedica Osteonics and Wright Medical combined exceed the core Stryker Corp count. This indicates that a large share of the company's Canadian catalog consists of orthopaedic reconstruction, joint replacements, and extremities implants.
Subsidiary Breakdown: Other active licensee entities include Tornier, Novadaq Technologies, and K2M.

3. Australia: TGA ARTG

The Australian Register of Therapeutic Goods (ARTG) is the repository of all medical devices approved for supply in Australia.

Denominator: 99,405 records.
Combined Stryker Matches: 1,964 sponsor or manufacturer listings.
Analysis: The database shows Stryker Australia Pty Ltd (the local Australian subsidiary) listed as the sponsor for 1,892 active entries. On the manufacturing side, legacy names remain prominent: Howmedica is listed as the manufacturer for 844 listings, and Wright/Tornier entities account for over 300 listings.

4. Brazil: ANVISA Registry

Brazil represents the largest healthcare market in Latin America and requires separate ANVISA registration for all devices.

Denominator: 111,789 active records.
Combined Stryker Matches: 998 registrations.
Analysis: Brazil's data is divided between the foreign manufacturer (Fabricante) and the local registration holder (Detentor). The local subsidiary, Stryker do Brasil Ltda, is listed as the detentor for 978 records, showing that Stryker directly owns and controls its registrations in Brazil.
Manufacturer Breakdown: The corresponding foreign manufacturers are Howmedica Osteonics (USA), Wright Medical Technology (USA), and Tornier SAS (France).

5. Saudi Arabia: SFDA Medical Equipment List

The Saudi Food and Drug Authority (SFDA) operates a strict registration system that serves as a benchmark for the Middle East.

Denominator: 163,185 records.
Combined Stryker Matches: 2,815 records.
Analysis: Saudi Arabia represents an exceptionally high record count for Stryker. This is driven by Howmedica (1,302 listings) and Stryker Corp (1,737 listings), reflecting a high density of orthopaedic implant systems.

6. South Korea: MFDS Device Registrations

South Korea's Ministry of Food and Drug Safety (MFDS) regulates medical devices via a strict licensing system.

Denominator: 273,672 records.
Combined Stryker Matches: 3,728 records.
Analysis: The local subsidiary Stryker Korea Co., Ltd. is highly active, managing registrations for manufacturing sites in Mahwah, NJ (Howmedica), Memphis, TN (Wright Medical), and Freiburg, Germany (Stryker Leibinger).

Acquisition Integration: Howmedica & Wright Medical in the Registries

Stryker's corporate strategy has been heavily driven by key acquisitions that expanded its product portfolio. The most notable orthopaedic and surgical acquisitions include:

Howmedica (acquired in 1998): The foundation of Stryker's reconstructive orthopaedic division.
Leibinger (acquired in 1998): Expanded Stryker into craniomaxillofacial (CMF) implants.
K2M (acquired in 2018): Strengthened Stryker's spine division.
Wright Medical Group (acquired in 2020, valued at approximately USD 5.4 billion in enterprise value): Wright Medical had previously acquired Tornier in 2015, making this transaction a double consolidation that established Stryker as a global leader in extremities (shoulder, elbow, hand, foot, and ankle) and biologics.

Legacy Entity Persistence

Updating global manufacturing labels is a massive regulatory undertaking. Consequently, Stryker continues to register products under legacy corporate names:

Canada MDALL: Of the 5,952 active registrations under the Stryker combined query, 3,099 are held under legacy subsidiary names, including Howmedica Osteonics Corp, Wright Medical Technology, and Tornier SAS, showing that legacy orthopaedic entities represent more than half of the active listings.
Saudi Arabia SFDA: Legacy Howmedica entities account for 1,302 entries, and Wright/Tornier account for 338 entries, compared to 1,737 under Stryker Corp.
Australia ARTG: Legacy names account for 844 of the 1,964 listings, with Howmedica representing the majority of legacy listings.

For regulatory affairs teams, this persistence means that when performing due diligence on a competitor's portfolio or seeking to transition a portfolio, one must search under all legacy names. A query restricted only to "Stryker" will miss more than half of the company's active product registrations in key markets.

SaMD and Robotic Systems: Mako Case Study

A critical area of Stryker's modern commercial success is its digital surgery and robotics platform. The Mako Robotic-Arm Assisted System represents a complex combination of capital hardware, single-use patient-specific instruments, and software modules.

From a regulatory standpoint, Capital Equipment like the Mako system must be registered differently from consumables:

Dual-Registration Pathway: In markets like South Korea (MFDS) and Taiwan (TFDA), the Mako robotic arm is registered as a Class III medical device under Capital Equipment, while the specific software modules for Mako Total Knee, Mako Total Hip, and Mako Partial Knee are registered separately as Software-as-a-Medical-Device (SaMD).
Software Updates (SaMD): Every time Stryker releases a major software update containing new surgical planning algorithms, it must secure regulatory clearance or notification in each international jurisdiction. In Australia (TGA), these updates are filed as variations to the existing ARTG entry, whereas in the US, they often require new 510(k) submissions.
HSA Singapore Registrations: Singapore's HSA registry shows that the Mako System and its corresponding planning software modules are registered directly by Stryker Singapore Private Limited, ensuring local clinical support and installation control.

Importer vs. Product Registration: Channel Footprint

In addition to product registries, mapping Stryker's local importer and distributor networks provides insight into its regional commercial strategies.

Direct Subsidiary vs. Third-Party Distributor

The data shows a clear pattern: in major, high-volume markets, Stryker operates via its own direct local subsidiaries, which act as the authorized importer or local representative of record. In smaller or more restricted markets, Stryker relies on third-party local distributors:

Singapore: Importer registries list Stryker Singapore Private Limited holding 18 active importer records, indicating direct operations.
Mexico: COFEPRIS holder databases list Stryker México, S.A. de C.V. holding 7 active holder records, showing direct control over registrations.
South Korea: Importer item caches list Stryker Korea Co., Ltd. as the direct importer of record for advanced systems like the Stryker Adapt Mobile Platform.
Brazil: The local trade association (ABRAIDI) lists Stryker do Brasil Ltda as a direct member, showing active local infrastructure.
Malaysia: The local association lists Stryker Corporation (M) Sdn Bhd as a direct member.
United Kingdom: Distributor databases list Stryker UK Ltd based in Newbury, Berkshire, managing direct regional warehousing and distribution.

This direct subsidiary model allows Stryker to maintain tight control over its local supply chain, manage price structures, and coordinate directly with ministries of health. In contrast, in markets like Kazakhstan or Argentina, registrations are often held by local third-party distributors or are registered at the product-brand level only, meaning Stryker must coordinate its regulatory strategy through external intermediaries.

Sourcing and Supply Chain Integration

Stryker's manufacturing network is highly globalized, which introduces unique regulatory and logistical dependencies. By analyzing the country of origin listed in global registries, we can map Stryker's manufacturing hubs:

Orthopedic Reconstruction (Mahwah, USA & Cork, Ireland): The FDA Registration & Listing and Canada MDALL databases show that a massive portion of Stryker's hip and knee implants are manufactured in Mahwah, New Jersey, and Cork, Ireland. Cork represents one of the largest orthopedic casting and machining facilities in the world.
Surgical Instruments & Robotics (Kalamazoo, USA): Registration details from the CDSCO and TGA reveal that Stryker's surgical handpieces, drills, and the Mako robotic system are primarily manufactured in Kalamazoo, Michigan.
Craniomaxillofacial & Micro-implants (Freiburg, Germany): The legacy Leibinger portfolios are concentrated in Freiburg, Germany, indicating specialized manufacturing clusters for CMF surgery.

For supply chain managers, this distribution highlights the risk of tariff exposure. Products imported into the US from Stryker's European facilities (such as Freiburg or Cork) face different tariff schedules compared to domestic US production.

FAQs

How many medical device registrations does Stryker have globally?

In the United States alone, Stryker holds over 79,000 active UDI listings, 2,056 510(k) clearances, and 279 PMA approvals. Internationally, its registrations range from hundreds to thousands of records per market, such as 5,952 in Canada, 1,964 in Australia, 519 in India, and 1,724 in Colombia.

Are Stryker's Howmedica and Wright Medical products still registered under legacy names?

Yes. Due to the high regulatory cost of updating global manufacturing labels, a large portion of Stryker's active registrations remain under legacy entity names, such as "Howmedica Osteonics Corp", "Wright Medical Technology, Inc.", or "Tornier SAS". In Canada, legacy names represent over 50% of Stryker's combined active registrations.

Does Stryker sell directly or through distributors in international markets?

Stryker utilizes a hybrid model. In major markets like Canada, South Korea, Singapore, and Mexico, Stryker operates via direct local subsidiaries (e.g., Stryker Canada, Stryker Korea, Stryker Singapore) that hold establishment licenses. In smaller or developing markets, Stryker partners with independent local distributors who manage local customs clearances.

What is the difference between product registration and importer establishment listings for Stryker?

Product registration (such as Canada MDALL or India CDSCO listings) authorizes a specific medical device to be sold in the market. Importer establishment listings (such as Singapore importer licenses or Korea importer registrations) license the physical business entity to import and distribute devices. A company must have both elements in place to legally commercialize a product.

Internal Links and Context

For information on specific orthopedic and surgical acquisitions, see our guide on the Stryker Amplitude Vascular Systems acquisition or the Stryker Inari Medical acquisition.
For information on MedTech supply chain impacts, read the Stryker Handala cyberattack guide.
For general supply chain strategies, consult our comprehensive Medical device supply-chain risk management guide.